Literature DB >> 1426385

Freezing cocultured human blastocysts.

Y Ménézo1, B Nicollet, N Herbaut, D André.   

Abstract

OBJECTIVE: To determine the possibility of obtaining good pregnancy rates (PRs) after freezing and thawing cocultured blastocysts.
DESIGN: Human blastocysts were frozen first according to a protocol available from literature. Two other protocols including the addition of glycerol were designed to improve the results.
SETTING: All the patients were under clinical management at the Institut Rhonalpin pour l'Etude de la Reproduction Humaine in Lyons, France. PATIENTS: Patients involved in the in vitro fertilization program have had their supernumerary embryos frozen according to the three protocols presented here. MAIN OUTCOME MEASURES: Embryo recovery after freezing and thawing. Clinical and ongoing pregnancies after embryo transfer (ET).
RESULTS: A protocol including sucrose addition and reduction of steps in the preparation of the blastocysts for freezing gave us a 21% PR per transfer (15 ongoing) of 101 transfers (106 thawings).
CONCLUSIONS: Freezing of cocultured human blastocysts allow good PRs. This can represent an alternative for repeated failures of ETs at early stages.

Entities:  

Mesh:

Year:  1992        PMID: 1426385     DOI: 10.1016/s0015-0282(16)55445-4

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  31 in total

1.  Successful Day 5 embryo transfer and pregnancies resulting after transport of embryos by air for biopsy and genetic analysis.

Authors:  M Langley; D Marek; J Cieslak; C Masciangelo; K M Doody; K J Doody
Journal:  J Assist Reprod Genet       Date:  2001-06       Impact factor: 3.412

2.  Cryopreservation of mouse embryos at morula/compact stage.

Authors:  J Tao; R Tamis; K Fink
Journal:  J Assist Reprod Genet       Date:  2001-04       Impact factor: 3.412

3.  Cryopreservation of embryos, blastocysts, and pregnancy rates of blastocysts derived from frozen-thawed embryos and frozen-thawed blastocysts.

Authors:  K Pantos; K Stefanidis; K Pappas; P Kokkinopoulos; K Petroutsou; G Kokkali; D Stavrou; V Tzigounis
Journal:  J Assist Reprod Genet       Date:  2001-11       Impact factor: 3.412

4.  Human pregnancies after transfer of fresh (four- to eight-cell) versus frozen-thawed blastocysts resulting from intracytoplasmic sperm injection.

Authors:  E J Servy; R A Kaufmann; Z Liu; Y Menezo; L Keskintepe
Journal:  J Assist Reprod Genet       Date:  1998-08       Impact factor: 3.412

5.  Clinical experiences of ICSI-ET thawing cycles with embryos cryopreserved at different developmental stages.

Authors:  Janos Konc; Katalin Kanyó; Sandor Cseh
Journal:  J Assist Reprod Genet       Date:  2005-05       Impact factor: 3.412

Review 6.  Potential use of embryo coculture with human in vitro fertilization procedures.

Authors:  J K Thibodeaux; R A Godke
Journal:  J Assist Reprod Genet       Date:  1995-11       Impact factor: 3.412

7.  Comparison of vitrified outcomes between human early blastocysts and expanded blastocysts.

Authors:  Wen-Yan Song; Xue-Gai Wang; Hai-Xia Jin; Gui-Dong Yao; Xiang-Yang Zhang; Sen-Lin Shi; Hong-Yi Yang; Zhao-Feng Peng; Ying-Pu Sun
Journal:  In Vitro Cell Dev Biol Anim       Date:  2016-03-08       Impact factor: 2.416

8.  Vitrification of human embryos subjected to blastomere biopsy for pre-implantation genetic screening produces higher survival and pregnancy rates than slow freezing.

Authors:  Levent Keskintepe; Geoffrey Sher; Anna Machnicka; Drew Tortoriello; Aykut Bayrak; Jeffrey Fisch; Yuksel Agca
Journal:  J Assist Reprod Genet       Date:  2009-12-05       Impact factor: 3.412

9.  Use of coculture with cumulus cells in insemination medium in human in vitro fertilization (IVF).

Authors:  P Quinn
Journal:  J Assist Reprod Genet       Date:  1994-05       Impact factor: 3.412

Review 10.  Factors affecting the outcome of human blastocyst vitrification.

Authors:  Amr A Kader; Audrey Choi; Yasser Orief; Ashok Agarwal
Journal:  Reprod Biol Endocrinol       Date:  2009-09-16       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.